Skip to main content

Advertisement

Table 1 Baseline characteristics

From: Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy

Characteristic Leiomyoma (N = 35) Uterine Cancer (N = 53)
Age 48 ± 6.5 [range 36–60] 60.1 ± 9.9 [range 38–81]
Race/ethnicity
 Caucasian 27 (77.1) 29 (54.7)
 African American 5 (14.3) 23 (43.4)
 Asian 0 (0) 1 (1.9)
 Hispanic 2 (5.7) 0 (0)
 Other 1 (2.9) 0 (0)
BMI 32.8 ± 9.2 [range 19.7–56.3] 37.5 ± 11.0 [range 19.2–64.5]
Paritya 1.5 ± 1.0 [range 0–3] 1.9 ± 1.8 [range 0–7]
Pre-op uterine size estimate (weeks)b 15.1 ± 2.7 [range 10–20] 10.7 ± 2.7 [range 6–14]
Menopausal 7 (20) 40 (75.5)
Prior Abdominal Surgery 23 (65.7) 27 (50.9)
Pre-op Diagnosis
 Leiomyoma 33 (94.3) 6 (11.3)
 Endometrial cancer 0 50 (94.3)
 Ovarian cyst/mass 10 (30.3) 2 (3.8)
 Otherc 10 (30.3) 7 (13.2)
  1. Data are n(%) or mean ± SD unless otherwise specified. Data are presented as two separate cohorts given different disease states
  2. aMissing data: n = 34 for leiomyoma group
  3. bMissing data: n = 21 for leiomyoma group, n = 17 for uterine cancer group
  4. cIncludes endometrial intraepithelial neoplasia (3), abnormal uterine bleeding (4), family history of cancer (1), terminal ileum cancer (1), anemia (1), breast cancer (1), pelvic pain (1) and history of rectovaginal fistula repair (1) in the leiomyoma group and postmenopausal bleeding (2), atypical glandular cells (2), cirrhosis (1), cervical stenosis (2), chronic kidney disease (1), ventral hernia (1), atypical spindle cells (1) and pelvic organ prolapse (1) for the endometrial cancer group